drugset / Trial / NCT02024152

Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg

NCT02024152

RandomizedCrossoverDouble-blindTreatment

Summary

This study is to investigate the pharmacokinetics (PK) together with the safety and tolerability of JDP-205 at 5 mg and 10 mg intravenous doses and 10 mg intramuscular dose, in comparison to the marketed cetirizine oral product Zyrtec® 10 mg tablets (an OTC product) in healthy male and female volunteers after a single dose administration.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetirizine Other / unclassified 10 mg Oral
Subject JDP-205 Unknown 5 mg Intravenous
Subject JDP-205 Unknown 10 mg Intravenous

Indications